Elizabeth Glaser Pediatric AIDS Foundation   Report issue

Foundation Phase 2 Phase 3
Founded: Washington DC United States (1988)

Organization Overview

First Clinical Trial
2002
NCT00209469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Elisabeth Glaser Pediatric AIDS Foundation | Elizabeth Glaser Pediatric AIDS Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Diseases, Metabolic (Phase 3)

HIV Infections (Phase 2)

Obesity (Phase 3)

Osteoporosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 7